Drug reference
reboxetine
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Central Nervous System (NRIs)
Mechanism of action
Reboxetine is primarily used to treat depression but has also been found useful in the treatment of narcolepsy and panic disorders. Reboxetine is a selective inhibitor of noradrenaline reuptake. It inhibits noradrenaline reuptake in vitro to a similar extent to the tricyclic antidepressant desmethylimipramine.
Common side effects
- Insomnia
- Agitation
- Dry mouth
- Constipation
- Decreased appetite
- Dizziness
- Anxiety
Related conditions
Frequently asked questions
What drug class is reboxetine?
reboxetine belongs to: Central Nervous System.
How does reboxetine work?
Reboxetine is primarily used to treat depression but has also been found useful in the treatment of narcolepsy and panic disorders. Reboxetine is a selective inhibitor of noradrenaline reuptake. It inhibits noradrenaline reuptake in vitro to a similar extent to the tricyclic antidepressant desmethylimipramine.
What are the common side effects of reboxetine?
Insomnia, Agitation, Dry mouth, Constipation, Decreased appetite, Dizziness, Anxiety
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.